|
|
xiii | |
|
|
|
The neuroscientific foundations of free will. |
|
|
|
|
|
3 | (1) |
|
Philosophical introduction, the free will debate |
|
|
4 | (2) |
|
The neurophysiology of free will |
|
|
6 | (10) |
|
Brain activation precedes movement decision |
|
|
6 | (2) |
|
Biasing freely willed decisions |
|
|
8 | (1) |
|
The feeling of agency (I am the one who's doing it) |
|
|
9 | (3) |
|
The neuroanatomical substrate of free will |
|
|
12 | (4) |
|
Conclusions from clinical and neurophysiological observations |
|
|
16 | (1) |
|
|
16 | (2) |
|
|
18 | (2) |
|
|
20 | (6) |
|
Functional exploration for neuropathic pain. |
|
|
|
|
|
|
|
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
The lower limb flexion reflex |
|
|
27 | (4) |
|
|
27 | (1) |
|
RIII reflex changes in neuropathic pain induced by supraspinal lesions |
|
|
28 | (1) |
|
RIII reflex changes in neuropathic pain induced by spinal cord lesions |
|
|
29 | (1) |
|
RIII reflex and non-pharmacological analgesic techniques |
|
|
30 | (1) |
|
Evoked potentials in the assessment of neuropathic pain |
|
|
31 | (11) |
|
|
31 | (1) |
|
SEP in the assessment of NP |
|
|
32 | (3) |
|
LEP in the assessment of NP |
|
|
35 | (1) |
|
Physiology, component structure and brain generators of LEPs |
|
|
35 | (1) |
|
|
36 | (6) |
|
Brain imaging in neuropathic pain |
|
|
42 | (10) |
|
Cerebral blood flow (CBF) studies |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
43 | (4) |
|
Opioid receptor studies using PET |
|
|
47 | (1) |
|
Opioid receptor availability changes in neuropathic pain |
|
|
47 | (2) |
|
Effects of analgesic motor cortex stimulation on brain opioid receptor availability |
|
|
49 | (3) |
|
|
52 | (1) |
|
|
53 | (13) |
|
Experimental reconstruction of the injured spinal cord. |
|
|
|
|
|
|
|
66 | (1) |
|
|
66 | (1) |
|
Short overview of the pathophysiology of SCI |
|
|
67 | (1) |
|
Experimental approaches to SCI repair |
|
|
68 | (1) |
|
Neurotrophic factors (NF) |
|
|
69 | (1) |
|
Neutralizing inhibitory factors in the CNS |
|
|
70 | (1) |
|
Blocking the myelin inhibitory molecules |
|
|
70 | (1) |
|
Enzymes degrading inhibitors of axonal growth |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (4) |
|
Embryonic stem cells (ESCs) |
|
|
72 | (1) |
|
Induced pluripotent stem cells (iPSCs) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
Peripheral nerves and Schwann cells |
|
|
75 | (1) |
|
Olfactory ensheathing glia (OEG) |
|
|
75 | (1) |
|
|
76 | (4) |
|
Materials in experimental spinal cord injury repair |
|
|
77 | (1) |
|
|
77 | (1) |
|
Physical and chemical modifications of biomaterials to improve new tissue formation |
|
|
78 | (1) |
|
|
78 | (1) |
|
Scaffolds with oriented pores |
|
|
79 | (1) |
|
|
80 | (1) |
|
|
80 | (3) |
|
Experimental models vs. clinical practice |
|
|
80 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
The role of neurosurgeons in the future treatment of SCI patients |
|
|
83 | (1) |
|
|
83 | (2) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (13) |
|
Advances in videoassisted anterior surgical approach to the craniovertebral junction. |
|
|
|
|
|
98 | (1) |
|
|
98 | (1) |
|
Classic transoral microsurgical approach |
|
|
99 | (1) |
|
|
100 | (1) |
|
Endoscopic assisted procedures |
|
|
101 | (7) |
|
|
101 | (1) |
|
Indications, advantages/disadvantages side-effects, putative complications |
|
|
102 | (1) |
|
|
103 | (1) |
|
|
103 | (3) |
|
Indications, advantages/disadvantages side-effects, putative complications |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
Indications, advantages/disadvantages side-effects, putative complications |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (4) |
|
|
|
Myelomeningocele (open spina bifida) -- surgical management. |
|
|
|
|
|
113 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (2) |
|
|
118 | (3) |
|
|
118 | (1) |
|
|
119 | (2) |
|
|
121 | (14) |
|
|
123 | (1) |
|
|
123 | (12) |
|
Fetal (in-utero) repair of myelomeningocele |
|
|
135 | (2) |
|
|
137 | (7) |
|
Chiari type I malformation in children. |
|
|
|
|
|
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (6) |
|
Historical excursus: the birth of a disease |
|
|
145 | (3) |
|
The search for diagnostic criteria |
|
|
148 | (1) |
|
Anatomical classification of Chiari I malformations |
|
|
149 | (2) |
|
|
151 | (10) |
|
Primary occipital hypoplasia |
|
|
152 | (1) |
|
Secondary underdevelopment of the posterior cranial fossa |
|
|
153 | (2) |
|
The dysgenetic hypotheses |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
Intratechal and intracranial hypotension |
|
|
157 | (1) |
|
Raised intracranial pressure |
|
|
158 | (1) |
|
The caudal traction theory |
|
|
159 | (1) |
|
|
159 | (2) |
|
|
161 | (3) |
|
|
164 | (5) |
|
|
165 | (1) |
|
|
166 | (2) |
|
|
168 | (1) |
|
|
169 | (6) |
|
|
169 | (4) |
|
|
173 | (2) |
|
|
175 | (21) |
|
|
175 | (2) |
|
|
177 | (6) |
|
|
183 | (2) |
|
The management of hydrocephalus |
|
|
185 | (1) |
|
A controversial issue: the "occult tethered cord" syndrome |
|
|
186 | (2) |
|
Craniovertebral instability |
|
|
188 | (1) |
|
Intraoperative neurophysiologic monitoring |
|
|
189 | (5) |
|
|
194 | (1) |
|
|
194 | (2) |
|
|
196 | (18) |
|
Treatment of infections of the spine. |
|
|
|
|
|
|
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (1) |
|
|
215 | (2) |
|
|
217 | (6) |
|
|
217 | (1) |
|
|
217 | (1) |
|
Imaging of spinal infection |
|
|
218 | (5) |
|
|
223 | (11) |
|
|
223 | (1) |
|
|
223 | (1) |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
227 | (1) |
|
|
227 | (1) |
|
Cervical spondylodiscitis |
|
|
227 | (2) |
|
Thoracic and lumbar spondylodiscitis |
|
|
229 | (4) |
|
Spinal epidural abscesses |
|
|
233 | (1) |
|
Duration of postoperative antibiosis |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
236 | (1) |
|
|
236 | (9) |
Author Index |
|
245 | (14) |
Subject Index |
|
259 | |